Making it Personal: The Prospects for Autologous Pluripotent Stem Cell-Derived Therapies
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, iPSC-based cell therapies are switching from autologous transplantation to allogeneic transplantation [81].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [81]
Citations
Cites
Immunogenicity of induced pluripotent stem cells
Zhao, T., Zhang, Z.-N., Rong, Z., & Xu, Y. (2011) · Nature · doi:10.1038/nature10135 · Cited by 1,444
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Copy number variation and selection during reprogramming to pluripotency
Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 954
Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A., et al. (2013) · Nature · doi:10.1038/nature11807 · Cited by 505
Grealish, S., Diguet, E., Kirkeby, A., Mattsson, B., Heuer, A., Bramoulle, Y., Van Camp, N., Perrier, A. L., Hantraye, P., Björklund, A., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.017 · Cited by 447
Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A., & Bolton, E. M. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.014 · Cited by 428
Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P., & Boyd, A. S. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.01.006 · Cited by 368
Cell-based therapies for Parkinson disease—past insights and future potential
Barker, R. A., Drouin-Ouellet, J., & Parmar, M. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.123 · Cited by 306
Self-citationLong-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease: Two Case Reports
Kefalopoulou, Z., Politis, M., Piccini, P., Mencacci, N., Bhatia, K., Jahanshahi, M., Widner, H., Rehncrona, S., Brundin, P., Björklund, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4749 · Cited by 300
Toward the development of a global induced pluripotent stem cell library
Turner, M., Leslie, S., Martin, N. G., Peschanski, M., Rao, M., Taylor, C. J., Trounson, A., Turner, D., Yamanaka, S., & Wilmut, I. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.08.003 · Cited by 245
RIKEN suspends first clinical trial involving induced pluripotent stem cells
Garber, K. (2015) · Nature Biotechnology · doi:10.1038/nbt0915-890 · Cited by 215
Nakajima, F., Tokunaga, K., & Nakatsuji, N. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0566 · Cited by 168
Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy
de Rham, C., & Villard, J. (2014) · Journal of Immunology Research · doi:10.1155/2014/518135 · Cited by 96
Longitudinal Studies of a B Cell–Derived Signature of Tolerance in Renal Transplant Recipients
Newell, K. A., Asare, A. L., Sanz, I., Wei, C., Rosenberg, A., Gao, Z., Kanaparthi, S., Asare, S. M., Lim, N., Stahly, M., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13480 · Cited by 95
Japanese woman is first recipient of next-generation stem cells
Cyranoski, D. (2014) · Nature · doi:10.1038/nature.2014.15915 · Cited by 89
Banking on iPSC- Is it Doable and is it Worthwhile
Solomon, S., Pitossi, F., & Rao, M. S. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9574-4 · Cited by 86
An eye to the future: Researchers debate best path for stem cell-derived therapies
Chakradhar, S. (2016) · Nature Medicine · doi:10.1038/nm0216-116 · Cited by 56
Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies
Carpenter, M. K., & Couture, L. A. (2010) · Regenerative Medicine · doi:10.2217/rme.10.55 · Cited by 32
The path forward: Letter to the Editor
Healios, K. K., & Kagimoto, H. T. S. (2015) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2015.004 · Cited by 1
Cited by
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
“These days iPSC-based cell therapies are switching from autologous transplantation to allogeneic transplantation [78].”
BackgroundUtility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
“More recently, iPSC-based cell therapies are switching from autologous transplantation to allogeneic transplantation [81].”
BackgroundGuhr, A., Kobold, S., Seltmann, S., Seiler Wulczyn, A. E. M., Kurtz, A., & Löser, P. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.06.012 · Cited by 58
“Whether autologous, personalized hiPSCs, or HLA-haplobanks of hiPSC lines, will become an affordable option for personalized medicine remains disputable (Blair and Barker, 2016).”
BackgroundGenomic Instability of iPSCs and Challenges in Their Clinical Applications
Yoshihara, M., Oguchi, A., & Murakawa, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_2 · Cited by 60
Metadata
- Authors
- Blair, N. F., & Barker, R. A.
- Affiliations
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Venue
- Regenerative Medicine
- Publisher
- Informa UK Limited
- Published
- 2016-06-27
- Volume
- 11
- Issue
- 5
- Pages
- 423-425
- ISSN
- 1746-0751 (ISSN-L)
- 1746-076X
- OpenAlex
- W2470078443
- Cited by
- 22
- References
- 19
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3 · 2016: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Regenerative Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- UK Regenerative Medicine Platform postdoctoral research associateship
- Medical Research Council
- Engineering and Physical Sciences Research Council
- NIHR Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- autologous stem cell therapy, pluripotent stem cells, personalized medicine, patient-specific cell therapy
- MeSH terms
- Animals, Humans, Transplantation, Autologous, Stem Cell Transplantation, Pluripotent Stem Cells, Tissue Culture Techniques, Bioengineering, Induced Pluripotent Stem Cells, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.